Visualization of the cortical dopamine transporter in type 1 and 2 alcoholics with human whole hemisphere autoradiography

European Neuropsychopharmacology

Volumn 16, Issue 8, 2006, Pages 552-560

  Tupala, Erkki ^a,b   Halonen, Pirjo ^b   Tiihonen, Jari ^a,c  

^a Niuvanniemen sairaala   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Alcohol induced disorders; Autoradiography; Dopamine; Ethanol induced nervous system disorders; Human brain; Transporters

Indexed keywords

DOPAMINE TRANSPORTER;

ADULT; AGED; ALCOHOLISM; ANTISOCIAL BEHAVIOR; ARTICLE; AUTORADIOGRAPHY; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEMISPHERE; HUMAN; HUMAN TISSUE; MALE; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TEMPORAL CORTEX;

ADULT; ALCOHOLISM; ANALYSIS OF VARIANCE; AUTORADIOGRAPHY; CEREBRAL CORTEX; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NORTROPANES; POSTMORTEM CHANGES; STATISTICS;

EID: 33750818409     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2006.02.008     Document Type: Article

References (69)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Third edition revised (1987), American Psychiatric Press, Washington, DC
2. Altman D.G. Practical Statistics for Medical Research (1999), CRC Press LLC, Boca Raton, Florida 455-460
3. Anderson S., Auquier A., Haunch W.W., Oakes D., Vandaele W., and Weisberg H.I. Statistical methods for comparative studies. Techniques for bias reduction: analysis of co-variance (1980), John Wiley and Sons, Inc., New York 140-160
4. Araki T., Kato H., Shuto K., Fujiwara T., and Itoyama Y. Effect of aging on dopaminergic receptors and uptake sites in the rat brain studied by receptor autoradiography. J. Neurol. Sci. 148 (1997) 131-137
5. 3H]dopamine uptake is similar in both the rat striatum and nucleus accumbens. Eur. J. Pharmacol. 173 (1989) 215-217
6. Boja J.W., Vaughan R., Patel A., Shaya E.K., and Kuhar M.J. The dopamine transporter. In: Niznik H.B. (Ed). Dopamine Receptors and Transporters: Pharmacology, Structure and Function (1994), Marcel Dekker Inc. Publisher, New York 645-668
7. Bowden C., Cheetham S.C., Lowther S., Katona C.L., Crompton M.R., and Horton R.W. Dopamine uptake sites, labelled with [3H]GBR12935, in brain samples from depressed suicides and controls. Eur. Neuropsychopharmacol. 7 (1997) 247-252
8. Cass W.A., Zahniser N.R., Flach K.A., and Gerhardt G.A. Clearance of exogenous dopamine in rat dorsal striatum and nucleus accumbens: role of metabolism and effects of locally applied uptake inhibitors. J. Neurochem. 61 (1993) 2269-2278
9. Cloninger C.R. The psychobiological regulation of social co-operation. Nat. Med. 1 (1995) 623-625
10. Cloninger C.R., Bohman M., and Sigvardsson S. Inheritance of alcohol abuse. Cross-fostering analysis of adopted men. Arch. Gen. Psychiatry 38 (1981) 861-868
11. Cohen J.A. A coefficient of agreement for nominal scales. Educ. Psychol. Meas. XX (1960) 37-46
12. Cohen J. Statistical power analysis for the behavioural sciences. second edition (1988), Lawrence Erlbaum Associates, Publishers, Hillsdale, New Jersey 40
13. Coyle J.T., and Snyder S.H. Catecholamine uptake by synaptosomes in homogenates of rat brain: stereospecificity in different areas. J. Pharmacol. Exp. Ther. 170 (1969) 221-231
14. Emond P., Garreau L., Chalon S., Boazi M., Caillet M., Bricard J., Frangin Y., Mauclaire L., Besnard J.-C., and Guilloteau D. Synthesis and ligand binding of nortropane derivatives: N-substituted 2β-carbomethoxy-3β-(4′-iodophenyl)nortropane and N-(3-Iodoprop-(2E)-enyl)-2β-carbomethoxy-3β-(3′,4′-disubstituted phenyl)nortropane. New high-affinity and selective compounds for the dopamine transporter. J. Med. Chem. 40 (1997) 1366-1372
15. Farde L., Halldin C., Muller L., Suhara T., Karlsson P., and Hall H. PET study of [11C]beta-CIT binding to monoamine transporters in the monkey and human brain. Synapse 16 (1994) 93-103
16. Gardner M.J., and Altman D.G. Statistics with Confidence. Confidence Intervals and Statistical Guidelines (1989), British Medical Journal, London
17. Giros B., el Mestikawy S., Bertrand L., and Caron M.G. Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett. 295 (1991) 149-154
18. Hall H., Sedvall G., Magnusson O., Kopp J., Halldin C., and Farde L. Distribution of D1 and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology 11 (1994) 245-256
19. 125I]PE2I. NeuroImage 1 (1999) 108-116
20. Hietala J., West C., Syvälahti E., Någren K., Lehikoinen P., Sonninen P., and Ruotsalainen U. Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacology (Berl.) 116 (1994) 285-290
21. Hitri A., Casanova M.F., Kleinman J.E., and Wyatt R.J. Fewer dopamine transporter receptors in the prefrontal cortex of cocaine users. Am. J. Psychiatry 151 (1994) 1074-1076
22. Hurd Y.L., Pristupa Z.B., Herman M.M., Niznik H.B., and Kleinman J.E. The dopamine transporter and dopamine D2 receptor messenger RNAs are differentially expressed in limbic- and motor-related subpopulations of human mesencephalic neurons. Neuroscience 63 (1994) 357-362
23. Iversen L.L., and Snyder S.H. Synaptosomes: different populations storing catecholamines and gamma-aminobutyric acid in homogenates of rat brain. Nature 220 (1968) 796-798
24. Jones S.R., Garris P.A., and Wightman R.M. Different effects of cocaine and nomifensine on dopamine uptake in the caudate-putamen and nucleus accumbens. J. Pharmacol. Exp. Ther. 274 (1995) 396-403
25. Kish S.J., Robitaille Y., el-Awar M., Clark B., Schut L., Ball M.J., Young L.T., Currier R., and Shannak K. Striatal monoamine neurotransmitters and metabolites in dominantly inherited olivopontocerebellar atrophy. Neurology 42 (1992) 1573-1577
26. Koob G.F., and Bloom F.E. Molecular and cellular mechanisms of drug dependence. Science 242 (1988) 715-723
27. Koob G.F., and Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 278 (1997) 52-58
28. Kuikka J.T., Tiihonen J., Bergström K.A., Karhu J., Räsänen P., and Eronen M. Abnormal structure of human striatal dopamine re-uptake sites in habitually violent offenders: a fractal analysis. Neurosci. Lett. 253 (1998) 195-197
29. Kuczenski R., and Segal D.S. Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine. J. Pharmacol. Exp. Ther 262 (1992) 1085-1094
30. Laine T.P.J., Ahonen A., Torniainen P., Heikkilä J., Pyhtinen J., Räsänen P., Niemelä O., and Hillbom M. Dopamine transporters increase in human brain after alcohol withdrawal. Mol. Psychiatry 4 (1999) 189-191
31. Landis J.R., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159-174
32. Lew R., Vaughan R., Simantov R., Wilson A., and Kuhar M.J. Dopamine transporters in the nucleus accumbens and the striatum have different apparent molecular weights. Synapse 8 (1991) 152-153
33. Lewis D.A., Melchitzky D.S., Sesack S.R., Whitehead R.E., Auh S., and Sampson A. Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization. J. Comp. Neurol. 432 (2001) 119-136
34. Mantere T., Tupala E., Hall H., Särkioja T., Räsänen P., Berström K., Callaway J., and Tiihonen J. Serotonin transporter distribution and density in the cerebral cortex of alcoholic and nonalcoholic comparison subjects. A whole-hemisphere autoradiography study. Am. J. Psychiatry 159 (2002) 599-606
35. Meister B., and Elde R. Dopamine transporter mRNA in neurons of the rat hypothalamus. Neuroendocrinology 58 (1993) 388-395
36. Melega W.P., Raleigh M.J., Stout D.B., Huang S.C., and Phelps M.E. Ethological and 6-[18F]fluoro-L-DOPA-PET profiles of long-term vulnerability to chronic amphetamine. Behav. Brain Res. 84 (1997) 259-268
37. Mozley D.P., Kim H.-J., Gur R.C., Tatsch K., Muenz L.R., McElgin W.T., Kung M.-P., Mu M., Myers A.M., and Kung H.F. Iodine-123-IPT SPECT imaging of CNS dopamine transporters: nonlinear effects of normal aging on striatal uptake values. J. Nucl. Med. 37 (1996) 1965-1970
38. Mundorf M.L., Joseph J.D., Austin C.M., Caron M.G., and Wightman R.M. Catecholamine release and uptake in the mouse prefrontal cortex. J. Neurochem. 79 (2001) 130-142
39. Niewenhuys R., Voogd J., and vanHuijzen C. The Human Central Nervous System. 3rd ed. (1988), Springer-Verlag, Berlin, Heidelberg
40. Ouchi Y., Yoshikawa E., Okada H., Futatsubashi M., Sekine Y., Iyo M., and Sakamoto M. Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for beta-CFT binding with positron emission tomography. Ann. Neurol. 45 (1999) 601-610
41. Paanila J., Eronen M., Hakola P., and Tiihonen J. Aging and homicide rates. J. Forensic Sci. 45 (2000) 390-391
42. Repo E., Kuikka J.T., Bergström K.A., Karhu J., Hiltunen J., and Tiihonen J. Dopamine transporter and D2-receptor density in late-onset alcoholism. Psychopharmacology (Berl.) 147 (1999) 314-318
43. Repo-Tiihonen E., Virkkunen M., and Tiihonen J. Mortality of antisocial male criminals. J. Forensic Psychiatr. 12 (2001) 677-683
44. Revay R., Vaughan R., Grant S., and Kuhar M.J. Dopamine transporter immunohistochemistry in median eminence, amygdala, and other areas of the rat brain. Synapse 22 (1996) 93-99
45. Rommelspacher H., Raeder C., Kaulen P., and Bruning G. Adaptive changes of dopamine-D2 receptors in rat brain following ethanol withdrawal: a quantitative autoradiographic investigation. Alcohol 5 (1992) 355-362
46. Sekine Y., Minabe Y., Ouchi Y., Takei N., Iyo M., Nakamura K., Suzuki K., Tsukada H., Okada H., Yoshikawa E., Futatsubashi M., and Mori N. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. Am. J. Psychiatry 160 (2003) 1699-1701
47. Self D.W., and Nestler E.J. Molecular mechanisms of drug reinforcement and addiction. Annu. Rev. Neurosci. 18 (1995) 463-495
48. Shapiro S.S., Wilk M.B., and Chen H.J. A comparative study of various tests for normality. J. Am. Stat. Assoc. 63 (1968) 1343-1372
49. 3H]dopamine uptake in rat striatum during aging. J. Neurochem. 56 (1991) 575-579
50. Staley J.K., Basile M., Flynn D.D., and Mash D.C. Visualizing dopamine and serotonin transporters in the human brain with the potent cocaine analogue [125I]RTI-55: in vitro binding and autoradiographic characterization. J. Neurochem. 62 (1994) 549-556
51. Swahn C.-G., Halldin C., Farde L., and Sedvall G. Synthesis of unlabelled, 3H- and 125I-labelled β-CIT and its φ-fluoroalkyl analogues β-CIT-FE and β-CIT-FP, including synthesis of precursors. J. Labelled Compd Radiopharm. 38 (1996) 675-685
52. Sweidan S., Edinger H., and Siegel A. D2 dopamine receptor-mediated mechanisms in the medial preoptic-anterior hypothalamus regulate effective defense behavior in the cat. Brain Res. 549 (1991) 127-137
53. Tiihonen J., Kuikka J., Bergström K., Hakola P., Karhu J., Ryynänen O.-P., and Föhr J. Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics. Nat. Med. 7 (1995) 654-657
54. Tiihonen J., Vilkman H., Räsänen P., Ryynänen O.-P., Hakko H., Bergman J., Hämäläinen T., Laakso A., Haaparanta-Solin M., Solin O., Kuoppamäki M., Syvälahti E., and Hietala J. Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography. Mol. Psychiatry 4 (1998) 156-161
55. Tupala E., Hall H., Särkioja T., Räsänen P., and Tiihonen J. Dopamine transporter density in nucleus accumbens of type 1 alcoholics. Lancet 355 (2000) 380
56. Tupala E., Kuikka J.T., Hall H., Bergström K., Särkioja T., Räsänen P., Mantere T., Hiltunen J., Vepsäläinen J., and Tiihonen J. Measurement of the striatal dopamine transporter in type 1 alcoholics using human whole hemisphere autoradiography and fractal analysis. NeuroImage 14 (2001) 87-94
57. Tupala E., Hall H., Bergström K., Särkioja T., Räsänen P., Mantere T., Callaway J., Hiltunen J., and Tiihonen J. Dopamine D2/D3-receptor and transporter densities in nucleus accumbens and amygdala of type 1 and 2 alcoholics. Mol. Psychiatry 6 (2001) 261-267
58. Tupala E., Hall H., Bergström K., Mantere T., Räsänen P., Särkioja T., and Tiihonen J. Dopamine D2 receptors and transporters in type 1 and 2 alcoholics measured with whole hemisphere autoradiography. Hum. Brain Mapp. 20 (2003) 91-102
59. Tupala E., Hall H., Mantere T., Räsänen P., Särkioja T., and Tiihonen J. Dopamine receptors and transporters in the brain reward circuits of type 1 and 2 alcoholics measured with whole hemisphere autoradiography. NeuroImage 19 (2003) 145-155
60. Tupala E., Halonen P., Hall H., Mantere T., Särkioja T., Räsänen P., and Tiihonen J. Different effect of age on dopamine transporters in the dorsal and ventral striatum of alcoholics and controls. Synapse 48 (2003) 205-211
61. Vander Borght T.M., Sima A.A., Kilbourn M.R., Desmond T.J., Kuhl D.E., and Frey K.A. [3H]methoxytetrabenazine: a high specific activity ligand for estimating monoaminergic neuronal integrity. Neuroscience 68 (1995) 955-962
62. Vogt B.A., and Pandya D.N. Cingulate cortex of rhesus monkey, II: cortical afferents. J. Comp. Neurol. 262 (1987) 271-289
63. Volkow N.D., Fowler J.S., Wang G.J., Logan J., Schlyer D., MacGregor R., Hitzemann R., and Wolf A.P. Decreased dopamine transporters with age in healthy human subjects. Ann. Neurol. 36 (1994) 237-239
64. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Hitzemann R., Ding Y.S., Pappas N., Shea C., and Piscani K. Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol., Clin. Exp. Res. 20 (1996) 1594-1598
65. Volkow N.D., Ding Y.-S., Fowler J.S., Wang G.-J., Logan J., Gatley S.J., Hitzemann R., Smith G., Fields S.D., and Gur R. Dopamine transporters decrease with age. J. Nucl. Med. 37 (1996) 554-559
66. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Franceschi D., Sedler M., Gatley S.J., Miller E., Hitzemann R., Ding Y.S., and Logan J. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J. Neurosci. 21 (2001) 9414-9418
67. Wu Q., Reith M.E.A., Kuhar M.J., Carroll F.I., and Garris P.A. Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission. J. Neurosci. 21 (2001) 6338-6347
68. Zar J.H. Biostatistical Analysis. second edition (1984), Prentice-Hall Inc., Englewood Cliffs, New Jersey 310-317
69. Zelnik N., Angel I., Paul S.M., and Kleinman J.E. Decreased density of human striatal dopamine uptake sites with age. Eur. J. Pharmacol. 126 (1986) 175-176